Connect with us
Biointaxis has received more than €2 million from the Center for Industrial Technological Development (Cdti), a public business entity whose objective is to promote innovation and...
With the $57 million (€50 million), SpliceBio aims to bring this strategy to the clinical phase (human trials) in about 2 to 3 years. Its aim...
LentiStem seeks more than half a million euros to advance gene therapy. The biotech company has raised $311,000 (€260,000) in public capital and is seeking to...
Germany is not yet particularly well positioned in research and development of novel gene and cell therapies. Most studies are carried out in the USA (48%)...
Evotec shares are showing a strong performance, as the price increased by 5.15% this week. The company is expanding its activities in the field of gene...
The global slowdown in economic growth has so far left Roche and Novartis' businesses untouched. Both drug manufacturers, based in Basel, are currently growing significantly faster...